Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

harmony biosciences holdings inc.

POPULAR ARTICLES

Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting

Life Science Investing

Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting

Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation

Life Science Investing

Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation

Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist for Central Disorders of Hypersomnolence

Life Science Investing

Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist for Central Disorders of Hypersomnolence

LATEST ARTICLES

Harmony Biosciences to Participate in Upcoming Investor Conferences

Life Science Investing

Harmony Biosciences to Participate in Upcoming Investor Conferences

Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M

Life Science Investing

Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

Life Science Investing

Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance

Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome

Life Science Investing

Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome

Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress

Life Science Investing

Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress

Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference

Life Science Investing

Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference

Latest News

Spartan Metals Terminates Investor Relations Agreement

Rio Silver Closes the Acquisition of the Maria Norte Ag-Au-Pb-Zn Property in Central Peru

InMed Provides Update on BayMedica Commercial Business

Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million

SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Transition Metal

XTM:CC

Silverco Mining

SICO:CC

Goldgroup Mining

GGA:CC

Sankamap Metals

SCU:CC

Charbone Hydrogen

CH:CC

Rio Silver

RYO:CA

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES